OMNIPAQUE - 0407-1413-10 - (Iohexol)

Alphabetical Index


Drug Information of OMNIPAQUE

Product NDC: 0407-1413
Proprietary Name: OMNIPAQUE
Non Proprietary Name: Iohexol
Active Ingredient(s): 647    mg/mL & nbsp;   Iohexol
Administration Route(s): INTRATHECAL; INTRAVASCULAR; INTRAVENOUS; ORAL
Dosage Form(s): INJECTION
Coding System: National Drug Codes(NDC)

Labeler Information of OMNIPAQUE

Product NDC: 0407-1413
Labeler Name: GE Healthcare Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA018956
Marketing Category: NDA
Start Marketing Date: 20060921

Package Information of OMNIPAQUE

Package NDC: 0407-1413-10
Package Description: 10 VIAL, GLASS in 1 BOX (0407-1413-10) > 10 mL in 1 VIAL, GLASS

NDC Information of OMNIPAQUE

NDC Code 0407-1413-10
Proprietary Name OMNIPAQUE
Package Description 10 VIAL, GLASS in 1 BOX (0407-1413-10) > 10 mL in 1 VIAL, GLASS
Product NDC 0407-1413
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Iohexol
Dosage Form Name INJECTION
Route Name INTRATHECAL; INTRAVASCULAR; INTRAVENOUS; ORAL
Start Marketing Date 20060921
Marketing Category Name NDA
Labeler Name GE Healthcare Inc.
Substance Name IOHEXOL
Strength Number 647
Strength Unit mg/mL
Pharmaceutical Classes Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA]

Complete Information of OMNIPAQUE


General Information